CVS Caremark Corporation (NYSE:CVS) | Study Commissioned by CVS Caremark Highlights Opportunities to Significantly Reduce Spending on Costly Specialty Medications

[PR Newswire] – WOONSOCKET, R.I., April 9, 2014 /PRNewswire/ — Specialty medications present a challenge for payers as costs for these expensive drugs consume an increasing portion of overall health care spending. In . . . → Read More: CVS Caremark Corporation (NYSE:CVS) | Study Commissioned by CVS Caremark Highlights Opportunities to Significantly Reduce Spending on Costly Specialty Medications Similar Articles: Market Update (NYSE:CVS): CVS Caremark Finalizes Previously Announced Settlement with Securities and Exchange Commission CVS Caremark Corporation (NYSE:CVS) | CVS Caremark Charitable Trust Invests Millions of Dollars in Access to Health Care for Underserved Populations CVS Caremark Corporation (NYSE:CVS) – CVS Caremark Awarded Integrated, 3-Year Blue Cross and Blue Shield Federal Employee Program (FEP) Contract